Biotech and Pharmaceuticals Pharmaceuticals

  • Jan 12- The S&P 500 and the Dow were set for their worst day since October as the lack of details on economic policy in Donald Trump's speech took the wind out of a record-setting post-election rally. He instead lashed out at U.S. spy agencies and media houses over what he called a' phony' Russia dossier. Trump also blasted pharmaceutical companies over high drug...

  • Bill George on pharma: I'm on Trump's side

    Discussing President-elect Trump's comments on the pharmaceutical industry with Bill George, Harvard Business School senior fellow and former Medtronic CEO.

  • Investor optimism regarding the outlook for European healthcare stocks continued to decline dramatically on Thursday.

  • The decision by the U.S. Federal Circuit Court of Appeals came in a case in which Lilly sought to block Teva and other defendants from launching generic versions of Alimta, one of its best-selling drugs, before patent protections fully expire in 2022..

  • A scientist works in a Merck research lab.

    Morgan Stanley's 2020 earnings-per-share estimate for Merck is $5.82 versus the Wall Street consensus of $4.97.

  • CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to consumers. The drugstore chain says it will charge $109.99 for a two-pack of the authorized generic version of Adrenaclick, a lesser-known...

  • TOKYO, Jan 12- Japan's Nikkei share average dropped to a near two-week low on Thursday after President-elect Donald Trump failed at a highly-anticipated media briefing to provide clarity on future fiscal policies. The Nikkei fell 1.2 percent to 19,134.70, the lowest closing level since Dec. 30. The pharmaceutical sector was battered, falling 2.8 percent, the...

  • KUALA LUMPUR, Malaysia— Asian shares were mixed Thursday following President-elect Donald Trump's press conference. Australia's S&P/ASX 200 slipped 0.1 percent to 5,766.90 and South Korea's Kospi gained 0.2 percent at 2,079.83. The S&P 500 index added 6.42 points, or 0.3 percent, to 2,275.32.

  • *Nikkei has gained 18 pct since Nov. 9. TOKYO, Jan 12- Japan's Nikkei share average dropped to a near two-week low on Thursday morning after President-elect Donald Trump failed to provide clarity on future fiscal policies in a highly-awaited press briefing. "He failed to deliver what the market has wanted to hear for all these weeks," said Hikaru Sato, a senior...

  • NEW YORK, Jan 11- U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are "getting away with murder" in what they charge the government for medicines, and promised that would change, sending drugs stocks sharply lower. "When the president-elect says we're going to negotiate drug pricing, you have to take that seriously, but at the same this...

  • Health care stocks fell sharply after President-elect Donald Trump said the government needs to overhaul how it buys drugs from pharmaceutical companies. The S&P 500 index gained 6.42 points, or 0.3 percent, to 2,275.32. The S&P 500 is down 1.66 points, or 0.1 percent.

  • NEW YORK, Jan 11- U.S. stocks ended higher after a choppy day on Wednesday as energy and technology gains countered a drop in healthcare stocks after President-elect Donald Trump said pharmaceutical companies were "getting away with murder" by charging high prices. They view the sector as uninvestible, and withdraw their money, " Brad Loncar, manager of the Loncar...

  • In a story Jan. 10 about Johnson& Johnson's plans to disclose some information on its prescription drug price increases, The Associated Press reported erroneously the use of the company's drug Xarelto. Johnson& Johnson to reveal average drug price increases. Health care giant Johnson& Johnson says it will soon disclose average increases in the list price of its...

  • NEW YORK, Jan 11- U.S. stocks ended higher on Wednesday after a day of choppy trading even as many investors fled drug stocks after President-elect Donald Trump said pharmaceutical companies were "getting away with murder" by charging high prices for drugs.

  • Jan 11- Nasdaq lost ground in choppy trading on Wednesday as investors fled drug stocks after President-elect Donald Trump said pharmaceutical companies were "getting away with murder" by charging high drug prices. Trump said he has also discussed making it easier to import cheaper drugs in his first formal news conference since the Nov. 8 election.

  • NEW YORK, Jan 11- U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are "getting away with murder" in what they charge the government for medicines, and promised that would change, sending drugs stocks sharply lower. "When the president-elect says we're going to negotiate drug pricing, you have to take that seriously, but at the same this...

  • Jan 11- AbbVie Inc Chief Executive Richard Gonzalez on Wednesday promised to keep all drug price increases in 2017 under 10 percent, becoming the third global drugmaker to publicly make that pledge. Speaking at the annual JP Morgan Healthcare Conference in San Francisco, Gonzalez said his company would raise prices just once this year, and the percentage...

  • Pharma lobby: Committed to working with Trump, Congress

    CNBC's Sue Herera reports on the response from the pharmaceutical lobby following President-elect Donald Trump's comments on the industry.

  • Analyst: Government wouldn't want to kill goose that lays golden egg

    Michael King, JMP Securities senior analyst, weighs in on the biotech sector as President-elect Donald Trump puts the pharmaceutical industry in his cross hairs, calling it "disastrous."

  • Rep. Tom Price, R-Ga.

    Trump's Obamacare remarks came at a news conference that was his first since being elected president of the United States.